首页 > 最新文献

Roczniki Akademii Medycznej w Bialymstoku (1995)最新文献

英文 中文
Assessment of quality of life, pain and effectiveness of treatment in palliative care patients. 姑息治疗患者的生活质量、疼痛和治疗效果评估。
E Mess, E Kempińska, W Leppert, D Krzyianowski

Purpose: Evaluation of quality of life, appraisal of pain quality and intensity, assessment of treatment and care effectiveness in palliative care patients treated at the in-patient Palliative Care Department in Czestochowa Province Hospital.

Material and methods: The study was performed in 50 randomly chosen patients at the in-patient Palliative Care Department in Czestochowa Province Hospital. The studied group comprised 22 women and 28 men. The trial lasted since October 2003 till April 2004 and this was longitudinal study. At the first assessment patients filled Modified Sheet Pain Assessment, Support Team Assessment Schedule (STAS) and Rotterdam Symptom Checklist (RSCL). At the second, third and fourth appraisal patients filled RSCL and STAS.

Results: In patients surveyed by STAS at the second assessment 52% of patients achieved very high scores (poor effectiveness of treatment and care), 32% high scores - unsatisfactory treatment and care, 15% average results (average treatment and care). Results of RSCL indicate for decrease in physical activity and global quality of life of terminal patients. At the fourth assessment after 4 weeks of the treatment nearly 80% patients assessed their physical state as low.

Conclusions: The results indicate that patients have poor performance status, no effective treatment is provided, psychological state is significantly impaired, and patients were forced to resign from social life because of cancer progression.

目的:评价切斯托霍瓦省医院姑息治疗部住院患者的生活质量、疼痛质量和强度、治疗和护理效果。材料和方法:本研究在切斯托霍瓦省医院姑息治疗部随机选择的50例患者中进行。研究对象包括22名女性和28名男性。试验从2003年10月持续到2004年4月这是一项纵向研究。在第一次评估中,患者填写了修改后的疼痛评估表、支持小组评估表(STAS)和鹿特丹症状检查表(RSCL)。在第二次、第三次和第四次评估时,患者填写RSCL和STAS。结果:在接受STAS第二次评估的患者中,52%的患者得分很高(治疗和护理效果差),32%的患者得分很高-治疗和护理不满意,15%的患者得分一般(平均治疗和护理)。RSCL结果显示晚期患者的身体活动和整体生活质量下降。在治疗4周后的第4次评估中,近80%的患者评估自己的身体状态为低。结论:患者表现状态不佳,未得到有效治疗,心理状态明显受损,患者因癌症进展而被迫退出社会生活。
{"title":"Assessment of quality of life, pain and effectiveness of treatment in palliative care patients.","authors":"E Mess,&nbsp;E Kempińska,&nbsp;W Leppert,&nbsp;D Krzyianowski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Evaluation of quality of life, appraisal of pain quality and intensity, assessment of treatment and care effectiveness in palliative care patients treated at the in-patient Palliative Care Department in Czestochowa Province Hospital.</p><p><strong>Material and methods: </strong>The study was performed in 50 randomly chosen patients at the in-patient Palliative Care Department in Czestochowa Province Hospital. The studied group comprised 22 women and 28 men. The trial lasted since October 2003 till April 2004 and this was longitudinal study. At the first assessment patients filled Modified Sheet Pain Assessment, Support Team Assessment Schedule (STAS) and Rotterdam Symptom Checklist (RSCL). At the second, third and fourth appraisal patients filled RSCL and STAS.</p><p><strong>Results: </strong>In patients surveyed by STAS at the second assessment 52% of patients achieved very high scores (poor effectiveness of treatment and care), 32% high scores - unsatisfactory treatment and care, 15% average results (average treatment and care). Results of RSCL indicate for decrease in physical activity and global quality of life of terminal patients. At the fourth assessment after 4 weeks of the treatment nearly 80% patients assessed their physical state as low.</p><p><strong>Conclusions: </strong>The results indicate that patients have poor performance status, no effective treatment is provided, psychological state is significantly impaired, and patients were forced to resign from social life because of cancer progression.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 Suppl 1 ","pages":"207-9"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25264170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of education at The Childbirth School on Breast Feeding. 分娩学校教育对母乳喂养的影响。
D Cwiek, R Czajka, E Grochans

Breast feeding is the only proper way to feed a newborn and a baby during the first several months of his life. The most professional way of preparation for natural feeding is The Childbirth School. Education ought to be continued in maternity wards. The aim of this study is to prove that women who participated in The Childbirth Courses are better motivated and prepared for breast feeding. Material and methodology. The research comprised 294 lying-in women hospitalized in maternity ward in Clinic of Obstetrics and Perinatology, Pomeranian Medical University in Szczecin from June 2001 to December 2002. The examined women were divided into two groups: Group I--"study group"--comprised 129 lying-in women who attended the childbirth school courses during at least one pregnancy, but no earlier than 2 years ago. Group II--"control group" (reference group)--included 165 lying-in women who did not participate in any organized forms of prenatal education. Every woman who agreed to participate in the research was accepted. There was applied analysis of lying-in woman's documentation and author's questionnaire which was also used for further research. As a result of the research it was found that The Childbirth School increases motivation for natural feeding and prepares women for this activity. It also showed that more emphasis should be given to childbirth education for puerperal women in maternity wards; it refers in special to those women who did not attend The Childbirth School.

母乳喂养是唯一正确的方式喂养新生儿和婴儿在他的生命的头几个月。准备自然喂养的最专业的方法是分娩学校。在产房应该继续进行教育。这项研究的目的是证明参加过分娩课程的妇女对母乳喂养有更好的积极性和准备。材料和方法。研究对象为2001年6月至2002年12月在什切青波美拉尼亚医科大学产科和围产期诊所产科病房住院的294名产妇。接受调查的妇女被分为两组:第一组——“学习组”——由129名在至少一次怀孕期间(但不早于2年前)参加分娩学校课程的产妇组成。第二组——“对照组”(参照组)——包括165名产妇,她们没有参加任何有组织的产前教育。每个同意参加这项研究的妇女都被接受了。对产妇资料和作者问卷进行了应用分析,并进行了进一步的研究。研究结果发现,分娩学校提高了自然喂养的动力,并为女性做好了准备。它还表明,应更加重视产房产褥期妇女的分娩教育;它特别指那些没有参加分娩学校的妇女。
{"title":"Influence of education at The Childbirth School on Breast Feeding.","authors":"D Cwiek,&nbsp;R Czajka,&nbsp;E Grochans","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Breast feeding is the only proper way to feed a newborn and a baby during the first several months of his life. The most professional way of preparation for natural feeding is The Childbirth School. Education ought to be continued in maternity wards. The aim of this study is to prove that women who participated in The Childbirth Courses are better motivated and prepared for breast feeding. Material and methodology. The research comprised 294 lying-in women hospitalized in maternity ward in Clinic of Obstetrics and Perinatology, Pomeranian Medical University in Szczecin from June 2001 to December 2002. The examined women were divided into two groups: Group I--\"study group\"--comprised 129 lying-in women who attended the childbirth school courses during at least one pregnancy, but no earlier than 2 years ago. Group II--\"control group\" (reference group)--included 165 lying-in women who did not participate in any organized forms of prenatal education. Every woman who agreed to participate in the research was accepted. There was applied analysis of lying-in woman's documentation and author's questionnaire which was also used for further research. As a result of the research it was found that The Childbirth School increases motivation for natural feeding and prepares women for this activity. It also showed that more emphasis should be given to childbirth education for puerperal women in maternity wards; it refers in special to those women who did not attend The Childbirth School.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 Suppl 1 ","pages":"185-8"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25265415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of mycological investigations in diagnostics of nail changes. 真菌学检查在指甲变化诊断中的重要性。
R Maleszka, V Ratajczak-Stefańska, D Mikulska

Unlabelled: The aim of the study was an analysis of correlation between mycological examination results and clinical features of changed toenails in patients that visited mycological laboratory due to suspected onychomycosis.

Material and methods: Samples of changed toenails were collected from 579 patients. From all that cases a precise patient's history was taken paying a special attention on previous antimycotic treatment. In the clinical examination features of toenail changes were estimated.

Results: Onychomycosis was confirmed by the mycological examination in 23.3% of patients and exclude in 56.3% of individuals. In 20.4% of all cases the fungi growth was not obtained despite of positive results of direct microscopic examination. Among the cultured fungi species the most frequently observed were strains of Trichophyton rubrum--46.6%. 46% of all patients were previously treated with antifungals but the therapy was not efficacious in 23% of them.

Conclusions: In all the cases of toenail changes it is important to take a precise patient's history, because it has an essential influence on the results of diagnostic examinations. Diagnosing onychomycosis one cannot rely only on the clinical examination because in over 50% of patients with typical for onychomycosis toenail changes the mycological examination do not confirm fungal infection.

未标记:该研究的目的是分析真菌学检查结果与因疑似甲真菌病而前往真菌学实验室的患者脚趾甲变化的临床特征之间的相关性。材料与方法:收集579例患者的趾甲标本。从所有这些病例中提取了精确的患者病史,并特别注意以前的抗真菌治疗。在临床检查中,评估了趾甲变化的特征。结果:经真菌学检查确诊的患者占23.3%,排除者占56.3%。在20.4%的病例中,尽管直接显微镜检查结果呈阳性,但未见真菌生长。在培养菌种中,最常见的是红毛菌(Trichophyton rubrum),占46.6%。46%的患者以前接受过抗真菌药物治疗,但其中23%的患者治疗无效。结论:在所有的趾甲改变病例中,准确的病史对诊断检查的结果有重要的影响。诊断甲真菌病不能仅仅依靠临床检查,因为在50%以上的典型甲真菌病患者的脚趾甲改变中,真菌学检查不能证实真菌感染。
{"title":"The importance of mycological investigations in diagnostics of nail changes.","authors":"R Maleszka,&nbsp;V Ratajczak-Stefańska,&nbsp;D Mikulska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>The aim of the study was an analysis of correlation between mycological examination results and clinical features of changed toenails in patients that visited mycological laboratory due to suspected onychomycosis.</p><p><strong>Material and methods: </strong>Samples of changed toenails were collected from 579 patients. From all that cases a precise patient's history was taken paying a special attention on previous antimycotic treatment. In the clinical examination features of toenail changes were estimated.</p><p><strong>Results: </strong>Onychomycosis was confirmed by the mycological examination in 23.3% of patients and exclude in 56.3% of individuals. In 20.4% of all cases the fungi growth was not obtained despite of positive results of direct microscopic examination. Among the cultured fungi species the most frequently observed were strains of Trichophyton rubrum--46.6%. 46% of all patients were previously treated with antifungals but the therapy was not efficacious in 23% of them.</p><p><strong>Conclusions: </strong>In all the cases of toenail changes it is important to take a precise patient's history, because it has an essential influence on the results of diagnostic examinations. Diagnosing onychomycosis one cannot rely only on the clinical examination because in over 50% of patients with typical for onychomycosis toenail changes the mycological examination do not confirm fungal infection.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 Suppl 1 ","pages":"36-8"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25264654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progresses in the medical treatment of advanced colorectal cancer. 晚期结直肠癌的医学治疗进展。
V Sultan-Amar, E Fabre-Guillevin, P Piedbois

In the last 2 decades, major progresses have been made in the management of patients with advanced colorectal cancer (ACC). The modulation of 5-fluorouracil (5-FU) by folinic acid (LV), followed by the introduction of irinotecan and oxaliplatin have significantly improved the outcome of these patients. New strategies consist of oral fluoropyrimidines, and of targeted agents to inhibit cancer signalisation.

在过去的二十年中,晚期结直肠癌(ACC)患者的治疗取得了重大进展。用亚叶酸(LV)调节5-氟尿嘧啶(5-FU),随后引入伊立替康和奥沙利铂,显著改善了这些患者的预后。新的策略包括口服氟嘧啶和靶向药物来抑制癌症信号。
{"title":"Progresses in the medical treatment of advanced colorectal cancer.","authors":"V Sultan-Amar,&nbsp;E Fabre-Guillevin,&nbsp;P Piedbois","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the last 2 decades, major progresses have been made in the management of patients with advanced colorectal cancer (ACC). The modulation of 5-fluorouracil (5-FU) by folinic acid (LV), followed by the introduction of irinotecan and oxaliplatin have significantly improved the outcome of these patients. New strategies consist of oral fluoropyrimidines, and of targeted agents to inhibit cancer signalisation.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"97-100"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of green tea on the activity of aldehyde dehydrogenase (ALDH) in the liver of rats during chronic ethanol consumption. 绿茶对慢性乙醇消耗大鼠肝脏醛脱氢酶活性的影响。
L Chrostek, W Tomaszewski, M Szmitkowski

Purpose: Alterations in the redox state during chronic ethanol consumption are associated with the oxidation of ethanol via alcohol and aldehyde dehydrogenase. Among various antioxidants present in food, strong antioxidative effects have been attributed to polyphenols of green tea. The aim of the present study was to investigate the effect of green tea consumption during chronic ethanol intake on the activity of aldehyde dehydrogenase in the liver of rats during maturation and aging.

Materials and methods: The activity of ALDH was measured in the livers of rats aged 2 (young), 12 (adult) and 24 months (old). The rats were fed with a control liquid Lieber DeCarli diet, control liquid diet containing green tea (3 g/l), ethanol liquid diet (with increasing ethanol dose from 2.3% to 7%) and ethanol liquid diet containing green tea.

Results: Chronic ethanol consumption significantly increased the liver ALDH activity in young and adult rats but decreased this activity in old animals. The drinking of green tea did not alter ALDH activity in ethanol-consuming rats. Drinking green tea alone significantly increased ALDH activity in young and adult rats but did not alter this activity in old rats.

Conclusions: These results demonstrate that green tea administered during chronic ethanol consumption does not prevent the changes in the hepatic ALDH activity in the rats at each age.

目的:慢性乙醇消耗过程中氧化还原状态的改变与乙醇通过乙醇和醛脱氢酶氧化有关。在食品中存在的各种抗氧化剂中,绿茶中的多酚具有很强的抗氧化作用。本研究旨在探讨慢性乙醇摄入对成熟和衰老大鼠肝脏醛脱氢酶活性的影响。材料与方法:测定2月龄(幼龄)、12月龄(成年)、24月龄大鼠肝脏ALDH活性。大鼠分别饲喂利伯德卡利对照液体日粮、绿茶对照液体日粮(3 g/l)、乙醇液体日粮(乙醇剂量从2.3%增加到7%)和绿茶乙醇液体日粮。结果:慢性乙醇消耗显著增加了幼龄和成年大鼠肝脏ALDH活性,但降低了老年大鼠肝脏ALDH活性。饮用绿茶并没有改变乙醇摄入大鼠的ALDH活性。单独饮用绿茶显著增加了年轻大鼠和成年大鼠的ALDH活性,但没有改变老年大鼠的这种活性。结论:这些结果表明,在慢性乙醇消耗期间给予绿茶并不能阻止各年龄大鼠肝脏ALDH活性的变化。
{"title":"The effect of green tea on the activity of aldehyde dehydrogenase (ALDH) in the liver of rats during chronic ethanol consumption.","authors":"L Chrostek,&nbsp;W Tomaszewski,&nbsp;M Szmitkowski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Alterations in the redox state during chronic ethanol consumption are associated with the oxidation of ethanol via alcohol and aldehyde dehydrogenase. Among various antioxidants present in food, strong antioxidative effects have been attributed to polyphenols of green tea. The aim of the present study was to investigate the effect of green tea consumption during chronic ethanol intake on the activity of aldehyde dehydrogenase in the liver of rats during maturation and aging.</p><p><strong>Materials and methods: </strong>The activity of ALDH was measured in the livers of rats aged 2 (young), 12 (adult) and 24 months (old). The rats were fed with a control liquid Lieber DeCarli diet, control liquid diet containing green tea (3 g/l), ethanol liquid diet (with increasing ethanol dose from 2.3% to 7%) and ethanol liquid diet containing green tea.</p><p><strong>Results: </strong>Chronic ethanol consumption significantly increased the liver ALDH activity in young and adult rats but decreased this activity in old animals. The drinking of green tea did not alter ALDH activity in ethanol-consuming rats. Drinking green tea alone significantly increased ALDH activity in young and adult rats but did not alter this activity in old rats.</p><p><strong>Conclusions: </strong>These results demonstrate that green tea administered during chronic ethanol consumption does not prevent the changes in the hepatic ALDH activity in the rats at each age.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"220-3"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The cumulative effect of nuclear factor-kappaB (NF-kappaB) inhibition and endothelins in early cerulein-induced acute pancreatitis in rats. 核因子- κ b (nf - κ b)抑制和内皮素在早期核蛋白诱导的急性胰腺炎中的累积效应。
J W Długosz, A Andrzejewska, K Nowak, E Wróblewski, A Dabrowski

Purpose: To assess effects of NF-kappaB activation inhibitor (pyrrolidine dithiocarbamate--PDTC) alone or with endothelins (ET-1, ET-2, ET-3) in early course of cerulein-induced acute pancreatitis (AP) in rats.

Material and methods: After 4 h of AP in Wistar rats, treated with PDTC 10 or 40 mg/kg or with PDTC 10 mg/kg and ET-1, ET-2 or ET-3, 0.5 or 1.0 nmol/kg twice i.p. in 1 h interval, free active trypsin (FAT), total potential trypsin (TPT) and lipase in 12000 x g supernatants of pancreatic homogenates, plasma alpha-amylase and histological changes were assayed. %FAT/TPT was an index of trypsinogen activation.

Results: %FAT/TPT significantly increased to 12.42 +/- 2.14%, lipase to 5.51 +/- 0.84 U/mg protein and alpha-amylase to 28.5 +/- 5.61 U/mL in AP vs 1.96 +/- 0.31%, 1.29 +/- 0.11 U/mg and 5.80 +/- 1.38 U/ml in healthy control. Higher dose PDTC attenuated trypsinogen activation to 3.01 +/- 0.53% and alpha-amylase to 15.3 +/- 1.38. PDTC and ET-1 attenuated %FAT/TPT to 2.55 +/- 0.18% with lower and 2.34 +/- 0.44% with higher dose. ET-3 was less effective than ET-1: 6.76 +/- 0.46% with lower dose. Lower doses of ET-1 and ET-2 with PDTC, diminished lipase activity to 2.60 +/- 0.36 and 2.94 +/- 0.33.

Conclusions: Cumulative attenuation of trypsinogen activation after lower dose of PDTC and ET-1 approximated the effect of higher dose of PDTC. Additional effect of ET-3 was weaker than ET-1, and ET-2 was ineffective in this respect. The combination of this NF-kappaB activation inhibitor and ET-1 could be beneficial in early course of edematous AP by attenuating of trypsinogen activation. However, it should be treated with caution because of some unfavorable effects on histological scores of pancreatic injury.

目的:评价NF-kappaB激活抑制剂(吡罗烷二硫代氨基甲酸酯—PDTC)单独或与内皮素(ET-1、ET-2、ET-3)联合应用对cerulein诱导的急性胰腺炎(AP)早期病程的影响。材料与方法:Wistar大鼠AP作用4 h后,分别给予PDTC 10或40 mg/kg或PDTC 10 mg/kg加ET-1、ET-2或ET-3、0.5或1.0 nmol/kg,每隔1 h ig 2次,测定胰腺匀浆上清12000 × g游离活性胰蛋白酶(FAT)、总势胰蛋白酶(TPT)和脂肪酶、血浆α -淀粉酶及组织学变化。%FAT/TPT为胰蛋白酶原活化指标。结果:AP组FAT/TPT比值为12.42 +/- 2.14%,脂肪酶为5.51 +/- 0.84 U/mg, α -淀粉酶为28.5 +/- 5.61 U/mL,而健康对照组为1.96 +/- 0.31%、1.29 +/- 0.11 U/mg和5.80 +/- 1.38 U/mL。较高剂量的PDTC将胰蛋白酶原活性降低至3.01 +/- 0.53%,α -淀粉酶活性降低至15.3 +/- 1.38。PDTC和ET-1分别使%FAT/TPT降低至2.55 +/- 0.18%和2.34 +/- 0.44%。ET-3与ET-1的差异为6.76 +/- 0.46%。低剂量的ET-1和ET-2与PDTC,降低脂肪酶活性为2.60 +/- 0.36和2.94 +/- 0.33。结论:低剂量的胰蛋白酶原和ET-1对胰蛋白酶原激活的累积衰减作用与高剂量的胰蛋白酶原作用相近。ET-3的附加作用弱于ET-1, ET-2在此方面无效。该NF-kappaB激活抑制剂与ET-1联合使用可通过减弱胰蛋白酶原的激活,在水肿性AP的早期过程中发挥有益作用。然而,由于对胰腺损伤的组织学评分有不利影响,应谨慎治疗。
{"title":"The cumulative effect of nuclear factor-kappaB (NF-kappaB) inhibition and endothelins in early cerulein-induced acute pancreatitis in rats.","authors":"J W Długosz,&nbsp;A Andrzejewska,&nbsp;K Nowak,&nbsp;E Wróblewski,&nbsp;A Dabrowski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To assess effects of NF-kappaB activation inhibitor (pyrrolidine dithiocarbamate--PDTC) alone or with endothelins (ET-1, ET-2, ET-3) in early course of cerulein-induced acute pancreatitis (AP) in rats.</p><p><strong>Material and methods: </strong>After 4 h of AP in Wistar rats, treated with PDTC 10 or 40 mg/kg or with PDTC 10 mg/kg and ET-1, ET-2 or ET-3, 0.5 or 1.0 nmol/kg twice i.p. in 1 h interval, free active trypsin (FAT), total potential trypsin (TPT) and lipase in 12000 x g supernatants of pancreatic homogenates, plasma alpha-amylase and histological changes were assayed. %FAT/TPT was an index of trypsinogen activation.</p><p><strong>Results: </strong>%FAT/TPT significantly increased to 12.42 +/- 2.14%, lipase to 5.51 +/- 0.84 U/mg protein and alpha-amylase to 28.5 +/- 5.61 U/mL in AP vs 1.96 +/- 0.31%, 1.29 +/- 0.11 U/mg and 5.80 +/- 1.38 U/ml in healthy control. Higher dose PDTC attenuated trypsinogen activation to 3.01 +/- 0.53% and alpha-amylase to 15.3 +/- 1.38. PDTC and ET-1 attenuated %FAT/TPT to 2.55 +/- 0.18% with lower and 2.34 +/- 0.44% with higher dose. ET-3 was less effective than ET-1: 6.76 +/- 0.46% with lower dose. Lower doses of ET-1 and ET-2 with PDTC, diminished lipase activity to 2.60 +/- 0.36 and 2.94 +/- 0.33.</p><p><strong>Conclusions: </strong>Cumulative attenuation of trypsinogen activation after lower dose of PDTC and ET-1 approximated the effect of higher dose of PDTC. Additional effect of ET-3 was weaker than ET-1, and ET-2 was ineffective in this respect. The combination of this NF-kappaB activation inhibitor and ET-1 could be beneficial in early course of edematous AP by attenuating of trypsinogen activation. However, it should be treated with caution because of some unfavorable effects on histological scores of pancreatic injury.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"230-6"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The force-frequency relationship in human heart failure: effect of pyruvate and isoproterenol. 心力衰竭的力-频率关系:丙酮酸和异丙肾上腺素的作用。
I Martisiene, V Gendviliene, D Zablockaite, H Gurskaite

Purpose: The purpose of present study was to investigate the effect of metabolic substrate pyruvate and beta-adrenergic agonist isoproterenol and combination of these agents on the force- and relaxation-frequency relationship in human heart failure.

Material and methods: The experiments were performed on isolated human ventricle strips from patients undergoing cardiac corrective open heart surgery, using conventional method of registration of electromechanical activity. The stimulation frequency of myocardial strips was 0.2, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 Hz.

Results: In control, i.e. at perfusion of myocardial strips by Tyrode solution and stimulation frequency 1 Hz, the contraction force (F) was 0.94 +/- 0.18 mN, half time of relaxation (tr)--178.8 +/- 9.3 ms (n= 12). Pyruvate (10 mmol/L) increased F to 176.0 +/- 13.4%, tr--104.6 +/- 3.1% (n=8, p<0.05) vs control. By the action of isoproterenol (10(-5) mol/L) F increased to 122.1 +/- 10.2%, tr decreased to 58.9 +/- 3.1% (n=4, p<0.05) vs control. The relationship of F and tr from stimulation frequency in the absence of pyruvate and isoproterenol was negative. Pyruvate and isoproterenol didn't alter the shape of force-frequency relationships but F was augmented at all stimulation frequencies. The positive inotropic effect of isoproterenol was potentiated by pyruvate.

Conclusions: Pyruvate and isoproterenol alone can improve cardiac contractility in wide-range of stimulation frequency. The combination of these inotropic agents results in even more effective increase of contractile performance and therefore may be of therapeutic value in heart failure.

目的:探讨代谢底物丙酮酸酯和-肾上腺素能激动剂异丙肾上腺素及其联用对心力衰竭的力-松弛-频率关系的影响。材料和方法:采用常规的机电活动登记方法,在心脏矫正直视手术患者的离体心室条上进行实验。心肌条刺激频率分别为0.2、0.5、1.0、1.5、2.0、2.5、3.0 Hz。结果:对照组,即Tyrode溶液灌注心肌条时,刺激频率为1 Hz,收缩力(F)为0.94 +/- 0.18 mN,半松弛时间(tr)为178.8 +/- 9.3 ms (n= 12)。丙酮酸(10 mmol/L)可使F升高至176.0 +/- 13.4%,tr升高至104.6 +/- 3.1% (n=8, p)结论:丙酮酸和异丙肾上腺素单用可在大范围刺激频率下改善心脏收缩力。这些肌力药物的联合使用可以更有效地提高收缩性能,因此可能对心力衰竭有治疗价值。
{"title":"The force-frequency relationship in human heart failure: effect of pyruvate and isoproterenol.","authors":"I Martisiene,&nbsp;V Gendviliene,&nbsp;D Zablockaite,&nbsp;H Gurskaite","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of present study was to investigate the effect of metabolic substrate pyruvate and beta-adrenergic agonist isoproterenol and combination of these agents on the force- and relaxation-frequency relationship in human heart failure.</p><p><strong>Material and methods: </strong>The experiments were performed on isolated human ventricle strips from patients undergoing cardiac corrective open heart surgery, using conventional method of registration of electromechanical activity. The stimulation frequency of myocardial strips was 0.2, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 Hz.</p><p><strong>Results: </strong>In control, i.e. at perfusion of myocardial strips by Tyrode solution and stimulation frequency 1 Hz, the contraction force (F) was 0.94 +/- 0.18 mN, half time of relaxation (tr)--178.8 +/- 9.3 ms (n= 12). Pyruvate (10 mmol/L) increased F to 176.0 +/- 13.4%, tr--104.6 +/- 3.1% (n=8, p<0.05) vs control. By the action of isoproterenol (10(-5) mol/L) F increased to 122.1 +/- 10.2%, tr decreased to 58.9 +/- 3.1% (n=4, p<0.05) vs control. The relationship of F and tr from stimulation frequency in the absence of pyruvate and isoproterenol was negative. Pyruvate and isoproterenol didn't alter the shape of force-frequency relationships but F was augmented at all stimulation frequencies. The positive inotropic effect of isoproterenol was potentiated by pyruvate.</p><p><strong>Conclusions: </strong>Pyruvate and isoproterenol alone can improve cardiac contractility in wide-range of stimulation frequency. The combination of these inotropic agents results in even more effective increase of contractile performance and therefore may be of therapeutic value in heart failure.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"241-3"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum endostatin levels in patients with lung carcinoma. 肺癌患者血清内皮抑素水平。
E Swidzińska, M Ossolińska, W Naumnik, S Trojan, E Chyczewska

Unlabelled: The purpose of our study was to evaluate the clinical usefulness of serum endostatin levels during chemotherapy of lung cancer in relation to the histopathological type of the tumor, clinical stage and response to therapy.

Materials and methods: Serum concentrations of endostatin were determined in 37 patients (24 with non-small cell lung cancer and 13 with small cell lung cancer), 10 healthy subjects constituted controls. To determine endostatin levels (ELISA), venous blood samples were collected from each patient before treatment and after 4-6 courses of chemotherapy.

Results: The serum concentrations of endostatin were found significantly higher in patients in comparison with controls (p=0.003). No statistically significant differences were established between the concentrations of endostatin with regard to such clinical features, as: performance status, clinical stage (III and IV) and histopathological type (non-small cell lung cancer and small cell lung cancer). The concentrations of endostatin did not change after chemotherapy. There was no change of endostatin concentration caused by the response to treatment.

Conclusions: The serum endostatin concentrations were elevated in lung cancer patients.

未标记:本研究的目的是评估肺癌化疗期间血清内皮抑素水平与肿瘤的组织病理类型、临床分期和治疗反应的临床意义。材料与方法:测定37例非小细胞肺癌患者血清内皮抑素浓度,其中非小细胞肺癌患者24例,小细胞肺癌患者13例,健康对照10例。在治疗前和化疗4-6个疗程后采集患者静脉血标本,测定血管内皮抑素水平(ELISA)。结果:患者血清内皮抑素浓度明显高于对照组(p=0.003)。内皮抑素浓度在表现状态、临床分期(III期和IV期)、组织病理类型(非小细胞肺癌和小细胞肺癌)等临床特征方面无统计学差异。化疗后内皮抑素浓度无变化。内皮抑素浓度未因治疗反应而改变。结论:肺癌患者血清内皮抑素水平升高。
{"title":"Serum endostatin levels in patients with lung carcinoma.","authors":"E Swidzińska,&nbsp;M Ossolińska,&nbsp;W Naumnik,&nbsp;S Trojan,&nbsp;E Chyczewska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>The purpose of our study was to evaluate the clinical usefulness of serum endostatin levels during chemotherapy of lung cancer in relation to the histopathological type of the tumor, clinical stage and response to therapy.</p><p><strong>Materials and methods: </strong>Serum concentrations of endostatin were determined in 37 patients (24 with non-small cell lung cancer and 13 with small cell lung cancer), 10 healthy subjects constituted controls. To determine endostatin levels (ELISA), venous blood samples were collected from each patient before treatment and after 4-6 courses of chemotherapy.</p><p><strong>Results: </strong>The serum concentrations of endostatin were found significantly higher in patients in comparison with controls (p=0.003). No statistically significant differences were established between the concentrations of endostatin with regard to such clinical features, as: performance status, clinical stage (III and IV) and histopathological type (non-small cell lung cancer and small cell lung cancer). The concentrations of endostatin did not change after chemotherapy. There was no change of endostatin concentration caused by the response to treatment.</p><p><strong>Conclusions: </strong>The serum endostatin concentrations were elevated in lung cancer patients.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"197-200"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. 低剂量罗非昔布、炎症和前列环素在急性冠脉综合征中的合成。
A M Kuklińska, W J Musiał, K A Kamiński, P Kralisz, W Modrzejewski, B Sobkowicz, S Dobrzycki, S Stec, I Wojtkowska

Purpose: To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up.

Material and methods: Twenty nine patients with ACS without ST elevation were randomized to simvastatin alone or together with low dose rofecoxib. Serum levels of interleukin 6 (IL-6), 6-keto-PGF-1alpha--stable product of prostacyclin (PGT2) and hs-C-reactive protein (hs-CRP) were assessed on enrollment and after 30-day follow up.

Results: Combination of rofecoxib with statin significantly decreased levels of hs-CRP after one month therapy (5.21 mg/l +/- 4.12 vs 2.11 mg/l +/- 2.1; p=0.0092). This effect was not evident in a group on statin alone (3.95 mg/l +/- 3.33 vs 2.48 mg/l +/- 2.39; p=0.31). 6-keto-PGF-1alpha increased not significantly in both groups. IL-6 concentration has not changed during follow up.

Conclusions: Low dose of selective COX-2 inhibitor exerts significant anti-inflammatory effect and does not diminish PG12 synthesis in study group of patients with ACS.

目的:评价低剂量罗非昔布对急性冠脉综合征(ACS)患者炎症介质和前列环素合成的影响。材料与方法:29例无ST段抬高的ACS患者随机接受辛伐他汀单用或低剂量罗非昔布联合治疗。在入组时和随访30天后评估血清白细胞介素6 (IL-6)、6-酮- pgf -1 α——前列环素(PGT2)稳定产物和hs- c反应蛋白(hs-CRP)水平。结果:罗非昔布联合他汀治疗1个月后显著降低hs-CRP水平(5.21 mg/l +/- 4.12 vs 2.11 mg/l +/- 2.1;p = 0.0092)。这种影响在单独使用他汀类药物的组中不明显(3.95 mg/l +/- 3.33 vs 2.48 mg/l +/- 2.39;p = 0.31)。6-酮- pgf -1 α在两组均无明显升高。随访期间IL-6浓度无变化。结论:低剂量选择性COX-2抑制剂对ACS患者具有明显的抗炎作用,且不影响PG12的合成。
{"title":"Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.","authors":"A M Kuklińska,&nbsp;W J Musiał,&nbsp;K A Kamiński,&nbsp;P Kralisz,&nbsp;W Modrzejewski,&nbsp;B Sobkowicz,&nbsp;S Dobrzycki,&nbsp;S Stec,&nbsp;I Wojtkowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the influence of low dose rofecoxib on inflammatory mediators and prostacyclin synthesis in patients with acute coronary syndromes (ACS) in a short-term follow up.</p><p><strong>Material and methods: </strong>Twenty nine patients with ACS without ST elevation were randomized to simvastatin alone or together with low dose rofecoxib. Serum levels of interleukin 6 (IL-6), 6-keto-PGF-1alpha--stable product of prostacyclin (PGT2) and hs-C-reactive protein (hs-CRP) were assessed on enrollment and after 30-day follow up.</p><p><strong>Results: </strong>Combination of rofecoxib with statin significantly decreased levels of hs-CRP after one month therapy (5.21 mg/l +/- 4.12 vs 2.11 mg/l +/- 2.1; p=0.0092). This effect was not evident in a group on statin alone (3.95 mg/l +/- 3.33 vs 2.48 mg/l +/- 2.39; p=0.31). 6-keto-PGF-1alpha increased not significantly in both groups. IL-6 concentration has not changed during follow up.</p><p><strong>Conclusions: </strong>Low dose of selective COX-2 inhibitor exerts significant anti-inflammatory effect and does not diminish PG12 synthesis in study group of patients with ACS.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"339-42"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cholecystokinin octapeptide (CCK-8) concentration in plasma is not affected in functional abdominal pain in children. 儿童功能性腹痛不影响血浆缩胆素八肽(CCK-8)浓度。
M Uścinowicz, M Kaczmarski

Purpose: Cholecystokinin regulates gut motility and visceral sensation. The aim of the study was to determine the diagnostic value of plasma cholecystokinin octapeptide (CCK-8) concentration in children with functional abdominal pain (FAP).

Material and methods: Fifty-two children (33 girls and 19 boys) aged 6-17 years with chronic abdominal pain were included in this study. On the basis of clinical data, results of endoscopy and Criteria for Functional Disorders the patients were divided into three groups: group 1--functional dyspepsia (FD), group 2--irritable bowel syndrome (IBS), group 3--non-specific FAP. The control group consisted of children without abdominal pain in anamnesis. CCK-8 concentrations in plasma were measured with radio immunoassay technique, after plasma extraction. In study protocol we analysed CCK-8 levels in fasting state and 15, 30, 60 minutes after a standard test meal.

Results: In the fasting state plasma levels of CCK-8 were similar in each group and in controls. In the IBS patients CCK-8 levels were not increased after meal. In groups 1, 3 and controls postprandial levels were higher when compared to fasting state (p<0.05). Area under curve of CCK-8 plasma concentration was the lowest in group 2, but not significant compared to controls and other groups. No correlation was found between main symptoms of FD and IBS and CCK-8 concentration in plasma.

Conclusions: We conclude that gut dysmotility and symptoms of functional abdominal pain in children are not concerned with alteration of plasma CCK-8 levels before and after meal.

目的:胆囊收缩素调节肠道运动和内脏感觉。本研究的目的是确定血浆胆囊收缩素八肽(CCK-8)浓度对功能性腹痛(FAP)患儿的诊断价值。材料与方法:52例6-17岁的慢性腹痛患儿(女孩33例,男孩19例)纳入本研究。根据临床资料,根据内镜检查结果和功能障碍标准将患者分为三组:1组-功能性消化不良(FD), 2组-肠易激综合征(IBS), 3组-非特异性FAP。对照组为无腹痛的健忘症患儿。血浆提取后,用放射免疫分析法测定血浆中CCK-8浓度。在研究方案中,我们分析了禁食状态和标准试餐后15、30、60分钟的CCK-8水平。结果:各组空腹血浆CCK-8水平与对照组相近。在IBS患者中,CCK-8水平在餐后没有升高。与空腹相比,1、3组和对照组的餐后CCK-8水平更高。结论:儿童肠道蠕动障碍和功能性腹痛症状与餐前和餐后血浆CCK-8水平的改变无关。
{"title":"Cholecystokinin octapeptide (CCK-8) concentration in plasma is not affected in functional abdominal pain in children.","authors":"M Uścinowicz,&nbsp;M Kaczmarski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Cholecystokinin regulates gut motility and visceral sensation. The aim of the study was to determine the diagnostic value of plasma cholecystokinin octapeptide (CCK-8) concentration in children with functional abdominal pain (FAP).</p><p><strong>Material and methods: </strong>Fifty-two children (33 girls and 19 boys) aged 6-17 years with chronic abdominal pain were included in this study. On the basis of clinical data, results of endoscopy and Criteria for Functional Disorders the patients were divided into three groups: group 1--functional dyspepsia (FD), group 2--irritable bowel syndrome (IBS), group 3--non-specific FAP. The control group consisted of children without abdominal pain in anamnesis. CCK-8 concentrations in plasma were measured with radio immunoassay technique, after plasma extraction. In study protocol we analysed CCK-8 levels in fasting state and 15, 30, 60 minutes after a standard test meal.</p><p><strong>Results: </strong>In the fasting state plasma levels of CCK-8 were similar in each group and in controls. In the IBS patients CCK-8 levels were not increased after meal. In groups 1, 3 and controls postprandial levels were higher when compared to fasting state (p<0.05). Area under curve of CCK-8 plasma concentration was the lowest in group 2, but not significant compared to controls and other groups. No correlation was found between main symptoms of FD and IBS and CCK-8 concentration in plasma.</p><p><strong>Conclusions: </strong>We conclude that gut dysmotility and symptoms of functional abdominal pain in children are not concerned with alteration of plasma CCK-8 levels before and after meal.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"257-60"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25755089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Roczniki Akademii Medycznej w Bialymstoku (1995)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1